Clinical Trial

Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France

Name: Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France — clinical trial record (NCT07729852)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This multicenter open-label extension study conducted in France is designed to provide ATH434 orally BID to eligible patients who completed the Phase 2 study ATH434-201, and who may benefit from this treatment according to the evaluation by the Investigator.

Trial Details

NCT Number	NCT07729852
Lead Sponsor	Alterity Therapeutics
Conditions	Multiple System Atrophy
Enrollment	5 participants
Start Date	2026-07
Primary Completion	2029-07 (estimated)
Study Completion	2029-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-28